What is the Future of RTK-targeted Cancer Therapies?
The future of RTK-targeted therapies looks promising with advancements in precision medicine. The development of more selective inhibitors, biomarker-driven treatment strategies, and the exploration of combination therapies hold potential to overcome resistance and improve patient outcomes. Ongoing research into the molecular mechanisms of RTK signaling and its role in cancer will continue to drive innovation in this field.
